Regulators in Michigan have recalled a series of cannabis edibles due to their high THC levels and non-compliant packaging.
The owners of a cannabis testing lab in Montana have shut the business down out of concern that a software, required by the state’s regulators, may be inadvertently approving un-tested cannabis.
Almost half of Maine’s medical cannabis products would fail the contaminant tests that the state’s recreational cannabis products are subjected to. That’s the conclusion of a study conducted by Maine’s own Office of Cannabis Policy (OCP).
One issue has come to divide the state’s legal cannabis industry in recent months: Aspergillus testing. Analytical Cannabis reached out to key figures on both side of the debate to find out why fungi testing has become so fraught.
In an email letter sent last week – seen by Analytical Cannabis – the Department of Cannabis Control (DCC) reminded licensed labs that they are “required to accurately report testing results for cannabis batches.”
The US Department of Health and Human Services (HHS) has recommended that cannabis be reclassified from Schedule I to the less restrictive Schedule III within the Controlled Substance Act.
Cannabis products in Oregon no longer have to be tested for Aspergillus fungi following a suspension order from the Oregon Court of Appeals.